INTRODUCTION
============

Prosthetic meshes are routinely used to repair abdominal wall hernias. One of the problems encountered with the available mesh products is postimplantation shrinkage or distortion, which can contribute to postoperative pain and hernia recurrence. The degree of shrinkage of polypropylene mesh has been reported to be 33% to 54% in animal studies.^[@B1]--[@B3]^

Mesh contraction is known to occur within the first 2 months after implantation.^[@B3]^ Explanted mesh from humans has been studied with regard to change in pore size and has demonstrated changes from a 58.5% increase to a 40% decrease; however, this study did not report on the overall change in the size of the entire piece of mesh.^[@B4]^

The available data on mesh shrinkage in humans is limited and includes a case report of an explanted piece of mesh that had shrunk and folded to 30% of its original size in a 22-year-old man who had the mesh removed to treat chronic pain.^[@B5]^ Other studies have reported mesh shrinkage in the range of 20% to 30% for flat mesh and up to 75% shrinkage with mesh plugs.^[@B6]--[@B8]^

Various types of fixation have been used to secure the mesh in preperitoneal hernioplasty to prevent mesh dislocation, which was seen consistently with no fixation and is a recognized cause of hernia recurrence.^[@B9]--[@B10]^ Mesh fixation however is associated with an increased incidence of chronic postoperative pain after preperitoneal hernioplasty.^[@B10]--[@B12]^ Mesh fixation is not the only known cause for chronic inguinodynia following hernia repair. Identified causes of chronic inguinodynia include mechanical pressure from mesh shrinkage or meshomas, periosteal reactions, scar tissue, perineural fibrosis, neural compression or traction, partial or complete nerve transection, as well as nerve entrapment or injury by tacks, staples, or sutures used for mesh fixation.^[@B13]^

Results from a swine study using a NiTiNol-framed hernia device demonstrated no change in the radiographic appearance of the device from the immediate postoperative X-ray and X-rays taken every 30 days until the final 90-day X-rays. The swine were sacrificed, and the devices were explanted and evaluated. There was no change in the size or shape of the devices explanted from the swine after 3 months compared with a similar new device.^[@B14]^ This study raised the question of whether similar results could be demonstrated when the device is used to repair inguinal hernias in humans.

PATIENTS AND MATERIALS
======================

Twenty patients aged 17 to 89 years (mean age, 58.1, median, 65) of which 17 were male and 3 were female had 27 inguinal hernias repaired utilizing an FDA-cleared NiTiNol framed, polypropylene mesh, hernia device (NFHD) (ReboundHRD®, MMDI, Plymouth, MN, USA). Five different sizes and shapes of devices were utilized **([Figure 1](#F1){ref-type="fig"})**. The decision as to which size or shape of device to use was determined at the time of surgery. This decision was based on the patient\'s anatomy, the size of the hernia, and the author\'s preference. All of the procedures were performed by the author at the Glacial Ridge Hospital in Glenwood, Minnesota. The patients were evaluated with a postoperative single view PA standing pelvis X-ray at a 30-degree caudal angle. The patients were then seen for a clinical examination and repeat X-ray (also taken as a 30-degree caudal angle) standing PA of the pelvis to assess the stability of the device after a minimum of 6 months postoperatively (range, 183 days to 341 days; mean, 227; median, 224). There were 17 indirect, 2 direct, and 8 indirect/direct (double or pantaloon) hernias repaired. Ten of the hernias were on the left, and 17 were on the right. While under general anesthesia, all of the patients had laparoscopic TAPP repairs without any type of device fixation. All of the initial postoperative X-rays and late postoperative X-rays were independently reviewed by 3 board certified radiologists. The NiTiNol frame of the device is radio-opaque and can be well visualized on a plain radiograph. Measurements of the device and skeletal anatomic landmarks were obtained by using the measurement function available with the PACS system \[7 Medical Systems 7i On Demand™ SUV Analysis tool (Standardized Uptake Value)\] on both sets of radiographs. To compensate for any differences that were due to positioning or distance differences, the measurements were equalized by using the formula in **[Figure 2](#F2){ref-type="fig"}**.

![Shapes and sizes of the NFHD devices used.](jls0021127220001){#F1}

![The formula above was used to correct for any confounding differences between the first and second X-ray measurements. Such differences may be due to subtle variations in patient positioning, the distance between the patient and the X-ray tube, or both of these.](jls0021127220002){#F2}

Measurements were compared for the cranial-caudal (CC) and the medial-lateral or oblique (ML) dimensions for the device and the patient\'s skeletal anatomy **([Figure 3](#F3){ref-type="fig"})**. The initial and late postoperative X-rays were compared and measured **([Figure 4](#F4){ref-type="fig"})** and the percentage of change for each dimension (ML and CC) and a combined percentage change was calculated. The X-rays were also evaluated for radiographic evidence of any device distortion or position change.

![The cranial-caudal (CC) and medial-lateral or oblique (ML) measurements of the NiTiNol frame and anatomic landmarks using the measurement function available with the PACS system \[7 Medical Systems 7i On Demand™ SUV Analysis tool (Standardized Uptake Value)\].](jls0021127220003){#F3}

![Side-by-side comparison measurements of the initial postoperative X-ray and the second postoperative X-ray (taken after a minimum of 6 months postoperatively).](jls0021127220004){#F4}

RESULTS
=======

Comparison of the measurements from the first and second radiographs **([Table 1](#T1){ref-type="table"})** revealed minimal change. Five of the devices demonstrated a minimal decrease in size between -0.2% and -1.6%, and in 22 of the devices there was a slight expansion ranging between +0.3% to +11.3%. The mean change for all devices was +2.5% in the cranial-caudal (CC) dimension and +1.6% in the medial-lateral or oblique (ML) dimension. The overall mean change was an increase of +2.0% in size. None of the devices demonstrated any evidence of breakage, fraying, or distortion of the NiTiNol frame. There was no notable change in the radiographic appearance of any of the devices with regard to device shape, contour, or position. None of the patients had developed a hernia recurrence. All of the patients were examined and interviewed at the time of the second X-ray. All of the patients when specifically questioned denied the presence of any pain, discomfort, or awareness of the device.

###### 

The measurements in [Table 1](#T1){ref-type="table"} are obtained from the initial and second X-rays (greater than 6 months postoperatively). Measurements of the NiTiNol frame and the anatomic landmarks in the cranial-caudal (CC) and medial-lateral or oblique (ML) dimensions are listed for both sets of X-rays. The percentage of change is calculated by using the formula in **[Figure 2](#F2){ref-type="fig"}**

  Patient, Age, Sex, Device Type   1ST X-ray[^a^](#TF1-1){ref-type="table-fn"}   2nd X-ray[^a^](#TF1-1){ref-type="table-fn"}   %change[^a^](#TF1-1){ref-type="table-fn"}                                                                      
  -------------------------------- --------------------------------------------- --------------------------------------------- ------------------------------------------- ----- ----- ----- ------------------ ------ ------ ------- ------- -------
  1\) 86 M, Hybrid                 Indirect L                                    129                                           100                                         143   362   125   97                 140    359    −1.0%   −2.2%   −1.6%
  2\) 46 M, Hybrid                 Direct/Indirect R                             100                                           97                                          167   243   109   114                181    269    0.6%    6.8%    3.7%
  3\) 46 M, Hybrid                 Direct/Indirect L                             117                                           105                                         158   297   145   112                183    338    8.1%    −7.1%   0.5%
  4\) 89 M, Hybrid                 Indirect R                                    136                                           123                                         215   324   132   120                205    316    1.7%    0.0%    0.9%
  5\) 89 M, Hybrid                 Indirect L                                    141                                           91                                          215   324   133   95                 205    316    −1.0%   6.9%    2.9%
  6\) 76 M, Hybrid                 Direct/Indirect R                             116                                           112                                         140   423   129   115                135    401    14.8%   7.9%    11.3%
  7\) 27 M, Hybrid                 Indirect R                                    120                                           122                                         175   309   134   124                176    323    11.1%   −2.9%   4.1%
  8\) 65 F, Dog Bone               Indirect R                                    109                                           104                                         120   322   116   110                120    329    6.4%    3.6%    5.0%
  9\) 27 M, Hybrid                 Indirect R                                    127                                           117                                         363   388   130   111                366    376    1.5%    −2.0%   −0.2%
  10\) 27 M, Hybrid                Indirect L                                    130                                           121                                         363   388   133   115                366    376    1.5%    −1.9%   −0.2%
  11\) 81 M, Hybrid                Direct/Indirect L                             125                                           114                                         144   368   127   115                143    360    2.3%    3.0%    2.7%
  12\) 29 M, Hybrid                Direct/Indirect R                             97                                            149                                         177   336   98    145                177    327    1.0%    −0.0%   0.5%
  13\) 53 M, SM Shield             Indirect R                                    123                                           132                                         183   365   123   133                170    366    7.1%    0.5%    3.8%
  14\) 45 M, LG Shield             Direct R                                      185                                           168                                         154   342   191   168                163    343    −2.1%   −0.3%   −1.4%
  15\) 45 M, LG Shield             Direct L                                      181                                           149                                         163   368   187   158                175    369    −4.0%   5.8%    0.9%
  16\) 87 M, LG Hybrid             Direct/Indirect R                             80                                            118                                         156   374   82    119                161    368    −0.7%   2.4%    0.9%
  17\) 17 F, Hybrid                Indirect R                                    128                                           124                                         149   329   131   126                150    332    1.7%    0.7%    1.2%
  18\) 44 M, LG Shield             Indirect R                                    154                                           136                                         171   247   155   147                167    251    3.0%    6.5%    4.7%
  19\) 44 M, SM Shield             Indirect L                                    131                                           113                                         171   247   126   115                167    251    −1.5%   0.1%    −0.7%
  20\) 75 M, SM Shield             Indirect L                                    72                                            130                                         164   243   68    127                146    227    5.4%    4.3%    4.8%
  21\) 71 M, LG Shield             Direct/Indirect R                             180                                           159                                         236   320   184   158                235    320    2.6%    −0.3%   1.0%
  22\) 70 M, LG Shield             Direct/Indirect R                             187                                           150                                         188   343   188   152                184    344    2.7%    1.0%    1.8%
  23\) 79 M, LG Hybrid             Indirect R                                    149                                           150                                         183   387   131   161                163    397    −1.1%   4.7%    0.6%
  24\) 79 M, LG Hybrid             Indirect L                                    159                                           153                                         193   387   135   158                163    397    0.4%    0.7%    0.6%
  25\) 65 F, SM Hybrid             Indirect R                                    102                                           131                                         346   344   101   129                339    340    1.0%    −0.4%   0.3%
  26\) 30 M, LG Hybrid             Indirect R                                    192                                           156                                         163   397   182   153                149    371    3.4%    4.6%    4.0%
  27\) 30 M, LG Hybrid             Indirect L                                    181                                           149                                         163   397   169   139                149    371    2.0%    −0.2%   0.9%
                                                                                                                                                                                             Average % Change   2.5%   1.6%   2.0%            

NFHD=NiTiNol Framed Hernia Device, Pt=Patient, CC=Cranial-Caudal Measurement, ML=Medial, Lateral, or Oblique Measurement. All measurements are in mm.

DISCUSSION
==========

The presence of the NiTiNol frame on this polypropylene mesh hernia device demonstrated a consistent maintenance of the radiographic appearance with regard to size, shape, and position without fixation after a minimum of 6 months postimplantation. The stability of the shape and size of the NiTiNol frame suggests that there would be minimal shrinkage or distortion of the lightweight macro porous polypropylene mesh used in this device as well. The ability to image and monitor the status of the NiTiNol frame (and indirectly the associated polypropylene mesh) is a new option for surgeons and patients not previously possible. This is accomplished with a plain, single-view radiograph. It is well established that the "inguinal floor" is a semi-concave 3-dimensional structure; however, the 2-dimensional imaging obtained with a plain radiograph demonstrated consistency with regard to the shape, size, and overall appearance of the devices evaluated.

Mesh shrinkage and "meshomas" are the result of fibrosis and scar contraction. The NiTiNol frame in this device keeps the mesh smooth and flat and provides a constant circumferential outward tension on the mesh to prevent wrinkling and contraction. The NiTiNol frame also affects the peripheral edge of the polypropylene mesh in such a way as to cause it to splay out which enhances the mesh adherence to the adjacent tissue. This feature results in a "Velcro-like" effect that stabilizes the device where positioned and contributes to the intransience of the device. This device therefore does not require any fixation, and no fixation of any type was used in any of the patients in this study. The ability to avoid mesh fixation eliminates the potential injury or impingement of nerves and blood vessels and also avoids the potential sites of traction that can be a source of pain from misplaced tacks or staples. The device is designed to conform to the patient\'s anatomy, and this self-seating feature may account for some of the minimal changes noted in the X-ray measurements.

The outlier in this study, patient 6, experienced an 11.3% overall increase in the size of his device. When comparing the first and second postoperative X-rays, it becomes apparent that the change is likely due to the overall expansion of the device. I believe this is the consequence of an inadequate preperitoneal dissection preventing the device from completely unfurling at the time of placement. In this case, the device expanded to the fully unfurled size and shape as seen on the second X-ray taken 292 days later **([Figure 5](#F5){ref-type="fig"})**.

![Side-by-side comparison of the initial and second X-ray (292 days postoperatively) of the outlier patient who had an 11.33% overall increase in size.](jls0021127220005){#F5}

CONCLUSIONS
===========

The radiographic appearance of the NiTiNol-framed, polypropylene mesh hernia device remains stable with regard to size, shape, and position 6 months after implantation when used for laparoscopic inguinal hernioplasty. The radiographic appearance of the device remained stable during the critical period of tissue ingrowth without the use of any fixation. The NiTiNol frame of this device provides the surgeon with a new option--the ability to consistently image a hernia device with a single-view plain radiograph. The reliability of the performance of the NiTiNol-framed hernia device in this initial study is encouraging. A larger trial with an extended follow-up interval of this device is warranted.
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